个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共7条记录  
  • GEMCITABINE ELAIDATE Cytotoxic Agent Oncolytic
    [作者:Venugopal, B; Evans, TRJ,期刊:Drugs of the Future, 页码:427-432 , 文章类型: Article,,卷期:2011年36-6]
  • Cemcitabine is an established chemotherapeutic agent for the treatment of a variety of malignancies, including pancreatic, bladder, breast and non-small cell lung cancers. Cemcitabine requires specialized nucleoside tran...
  • ON 01910.Na Polo-Like Kinase Inhibitor Oncolytic
    [作者:Taft, DR; Dave, R; Gillum, AM; Maniar, M,期刊:Drugs of the Future, 页码:433-440 , 文章类型: Article,,卷期:2011年36-6]
  • ON 07970.Na (rigosertib, Estybon (R)) is a novel small molecule developed to treat cancer. It has a multitargeted mechanism of action, including polo-like kinase inhibition, resulting in selective blockade of mitosis and...
  • SECUKINUMAB Fully Human Anti-IL-17 Monoclonal Antibody
    [作者:Gonzalez-Gonzalez, LA; Foster, CS,期刊:Drugs of the Future, 页码:441-445 , 文章类型: Article,,卷期:2011年36-6]
  • Secukinumab (AIN-457) is a fully human monoclonal antibody that neutralizes IL-17, thus affecting the immune response driven by Th17 lymphocytes. The Th17 response has been described to contribute to the inflammatory rea...
  • THERAPEUTIC TARGETS FOR ANXIETY DISORDERS
    [作者:Sorbera, LA; Dulsat, C; Rosa, E,期刊:Drugs of the Future, 页码:473-484 , 文章类型: Article,,卷期:2011年36-6]
  • Anxiety disorders are a group of psychiatric illnesses characterized by extreme or pathological anxiety, resulting in alterations in mood or emotional tone. They are the most frequent of all mental disorders encountered ...